Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Primary Purpose:
Secondary purpose:
Analyze risk factors of HEV infection.
This is an Epidemiological study manufactured by Xiamen University. The primary purpose of this study is to evaluate the prevalence and incidence of HEV infection in MHD patients and to compare differences between the MHD patients and the control. The secondary purpose of this study is to analyze risk factors of the infection of HEV. There are two phases in this study. The first phase is a cross-sectional study. Approximately 200 MHD patients will be enrolled in MHD patient group, followed by control group's enrollment according to the age and gender of the MHD patient group. Blood samples and questionnaire were got at this time. Secondly, 100 enrolled volunteers in each group who is negative for HEV-IgM、HEV-IgG、HEV RNA will be introduced into the cohort study. The MHD patient group will been taken blood samples at an interval of 3 month until the 12th month after the first phase, however, the control group only need one blood sample at 12th month.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control group, disease history | people who didn't have disease history of Maintenance Hemodialysis | ||
| The MHD patient group, diseases history | Maintenance Hemodialysis Patients |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| prevalence of HEV infection | number and rate of participants with abnormal laboratory values in the MHD patients and the control; | up to 1 year after enrollment |
| new-infection rate of HEV infection | number and rate of the participants who's baseline laboratory value is normal and change to abnormal during the follow-up in the MHD patients and the control | up to 1 year after enrollment |
| Measure | Description | Time Frame |
|---|---|---|
| risk factors of HEV infection | the odd ratio(OR) and 95%CI of the factors such as age gender for HEV infection in the MHD patients and the control | up to 1 year after enrollment |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
200 each for the MHD patient group and the control group
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jianjun Niu, M.Sc. | Zhongshan Hospital Xiamen University | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D016751 | Hepatitis E |
| ID | Term |
|---|---|
| D006525 | Hepatitis, Viral, Human |
| D014777 | Virus Diseases |
| D007239 | Infections |
| D012327 | RNA Virus Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
| D006505 |
| Hepatitis |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |